Elixir Names Praecis COO William Heiden President And CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
The ex-Schering-Plough exec most recently served as president and COO of Praecis. Elixir's previous CEO resigned to facilitate the firm's transition into a drug development company with a focus on near-term commercial opportunities.